Us Bancorp \De\ Emergent Bio Solutions Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 265 shares of EBS stock, worth $2,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

265

Previous 265 -0.0%

Holding current value

$2,231

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.5 - $3.41 $526 - $1,196	-351 Reduced 56.98%	265 $0
Q4 2023 Feb 09, 2024	SELL	$1.82 - $3.16 $112 - $195	-62 Reduced 9.14%	616 $1,000
Q3 2023 Nov 03, 2023	SELL	$3.17 - $7.91 $551 - $1,376	-174 Reduced 20.42%	678 $2,000
Q2 2023 Aug 09, 2023	SELL	$7.35 - $13.21 $9,599 - $17,252	-1,306 Reduced 60.52%	852 $6,000
Q1 2023 May 09, 2023	SELL	$7.79 - $16.29 $13,398 - $28,018	-1,720 Reduced 44.35%	2,158 $22,000
Q4 2022 Feb 13, 2023	SELL	$11.0 - $21.45 $10,175 - $19,841	-925 Reduced 19.26%	3,878 $45,000
Q3 2022 Oct 27, 2022	BUY	$20.09 - $35.8 $24,369 - $43,425	1,213 Added 33.79%	4,803 $101,000
Q2 2022 Aug 01, 2022	SELL	$27.42 - $43.63 $29,092 - $46,291	-1,061 Reduced 22.81%	3,590 $112,000
Q1 2022 May 11, 2022	SELL	$36.48 - $52.22 $57,455 - $82,246	-1,575 Reduced 25.3%	4,651 $191,000
Q4 2021 Feb 11, 2022	BUY	$33.11 - $55.01 $49,499 - $82,239	1,495 Added 31.6%	6,226 $271,000
Q3 2021 Nov 10, 2021	BUY	$50.07 - $66.05 $4,055 - $5,350	81 Added 1.74%	4,731 $237,000
Q2 2021 Aug 05, 2021	SELL	$56.61 - $80.46 $204,248 - $290,299	-3,608 Reduced 43.69%	4,650 $293,000
Q1 2021 Apr 28, 2021	SELL	$86.23 - $125.19 $399,503 - $580,005	-4,633 Reduced 35.94%	8,258 $767,000
Q4 2020 Feb 04, 2021	BUY	$79.17 - $111.47 $316,442 - $445,545	3,997 Added 44.94%	12,891 $1.16 Million
Q3 2020 Nov 10, 2020	BUY	$81.91 - $134.94 $293,893 - $484,164	3,588 Added 67.62%	8,894 $919,000
Q2 2020 Aug 07, 2020	SELL	$54.33 - $89.52 $59,545 - $98,113	-1,096 Reduced 17.12%	5,306 $419,000
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $55,162 - $76,873	-1,118 Reduced 14.87%	6,402 $370,000
Q4 2019 Feb 04, 2020	SELL	$51.21 - $59.06 $15,567 - $17,954	-304 Reduced 3.89%	7,520 $405,000
Q3 2019 Nov 08, 2019	SELL	$40.6 - $57.2 $82,458 - $116,173	-2,031 Reduced 20.61%	7,824 $409,000
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $531,694 - $717,361	-13,319 Reduced 57.47%	9,855 $476,000
Q1 2019 May 08, 2019	BUY	$48.23 - $66.16 $58,888 - $80,781	1,221 Added 5.56%	23,174 $1.17 Million
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $117,045 - $154,096	-2,104 Reduced 8.75%	21,953 $1.3 Million
Q3 2018 Nov 01, 2018	SELL	$52.05 - $66.51 $65,999 - $84,334	-1,268 Reduced 5.01%	24,057 $1.58 Million
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $85,060 - $97,926	-1,760 Reduced 6.5%	25,325 $1.28 Million
Q1 2018 May 08, 2018	SELL	$44.44 - $54.39 $66,348 - $81,204	-1,493 Reduced 5.22%	27,085 $1.43 Million
Q4 2017 Feb 02, 2018	SELL	$37.77 - $47.75 $336,908 - $425,930	-8,920 Reduced 23.79%	28,578 $1.33 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $1.28 Million - $1.52 Million	37,498	37,498 $1.52 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account